Montevisine drops 0.05% 10ml

Montevisine instruction for use

Reed more and buy Montevisine on this page

Composition

1 ml of solution contains:

Active substance: tetrahydrozoline hydrochloride (tetrisoline hydrochloride) 0.5 mg;
Excipients: benzalkonium chloride 0.1 mg, disodium edetate, sodium chloride, boric acid, sodium tetraborate (borax), water for injection.
Description: clear, colorless solution
Pharmacotherapeutic group: alpha-adrenomimetic
ATX Code S01GA02

PHARMACOLOGICAL PROPERTIES

Alpha-adrenostimulant, it has a vasoconstrictive and anticongestive action.
The vasoconstrictor effect without secondary reactive hyperemia develops within a few minutes and persists for 4-8 hours. In local applications, systemic absorption is low.

Indications for use

Edema of the conjunctiva, secondary hyperemia with allergic eye diseases, irritation of the conjunctiva.
Hyperemia and / or edema of the conjunctiva caused by various non-specific causes: state after tonometry, dust, cigarette smoke, smog, swimming, reading, driving.

Contraindications for Montevisine

Hypersensitivity to one of the components of Montevisine, glaucoma, children's age (up to 6 years), endothelial-epithelial dystrophy of the cornea, pregnancy and lactation.
With caution: arterial hypertension, arrhythmias, aneurysm, thyrotoxicosis, pheochromocytoma, diabetes mellitus, severe organic diseases of the heart and blood vessels (including coronary heart disease); period of treatment with MAO inhibitors and other drugs that increase blood pressure.

Dosing and Administration

Locally. 1-2 drops in each conjunctival sac 2-3 times a day.
If the improvement does not occur within 48 hours, further reception should be discontinued and consult a doctor.

Side effects of Montevisine

Mydriasis, increased intraocular pressure, reactive hyperemia, lacrimation, burning sensation in the eye.
Systemic effects (possible with the administration of a large amount of Montevisine): headache, nausea, drowsiness, weakness, tremor, dizziness, insomnia, palpitations, tachycardia, hyperglycemia, increased blood pressure, cardiac dysfunction, allergic reactions.

Overdose

Symptoms: mydriasis, cyanosis, fever, seizures, arrhythmias, increased blood pressure, pulmonary edema, dyspnoea, cardiac arrest. Excessive general absorption of imidazole derivatives can lead to central nervous system depression, accompanied by drowsiness, hypothermia, bradycardia, collapse, apnea and coma. The risk of overdose symptoms associated with drug absorption is high in young children, especially if swallowed.
Treatment: antidote is unknown. Assign activated charcoal, gastric lavage, inhalation of oxygen, antipyretic and antiepileptic drugs. To reduce blood pressure - fentolamine 5 mg on physiological solution slowly in / in or 100 mg orally.

special instructions for Montevisine

Use within 30 days after opening the vial.
Avoid prolonged use and overdose, especially in children.
If eye disease is not an obstacle to wearing contact lenses, they should be removed before instillation of the drug and set after about 15 minutes. Avoid direct contact of eye drops with soft contact lenses, considering the risk of their transparency being impaired.
During the period of treatment, it is necessary to refrain from engaging in potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions (the possibility of developing a visual impairment).
If the condition does not improve within 48 hours, or irritation and hyperemia of the eyes persist or build up, you should cancel the drug and consult a doctor. If you have intense pain in the eyes, headache, loss of vision, sudden appearance of "floating" spots before your eyes, redness of the eyes, pain when exposed to light or doubling in the eyes, you should immediately consult a doctor.

Drug Interactions

Incompatible with MAO inhibitors, tricyclic antidepressants, maprotiline (the possibility of developing a hypertensive crisis), as with inhalational anesthetics (eg cyclopropane, halothane and other halogenated anesthetics that can cause ventricular fibrillation)

Form of issue

Eye drops 0.05%. To 10 ml in a bottle of colorless glass, ukuporenny rubber stopper with a metal cap. 1 bottle together with a dispensing nozzle and instructions but for medical use is placed in a cardboard pack.

Storage conditions

At a temperature of 15 to 25 ° C, protected from light, out of reach of children.
Shelf life - 3 years.
Do not use after the expiry date printed on the package.

Vacation from pharmacies

To buy Montevisine you don't need a prescription.